The influence of ROS1 fusion partners and resistance mechanisms in ROS1-TKI-treated non-small cell lung cancer patients
Zwierenga, Fenneke; Dijkhuizen, Christa (Biomolecules & Health); Korthuis, Patrick; Timens, Wim; Groen, Harry; Hiltermann, Jeroen; van den Berg, Anke; Drayer, Lyndsay; van der Wekken, Anthonie
Infectieziekten (en vaccines)
Milder, Fin
ROS1+ in vitro models
Dijkhuizen, Christa (Biomolecules & Health); Korthuis, Patrick; Aguado, Cristina; Garcia-Román, Silvia; Aguilar-Hernández, Andrés; Drayer, Lyndsay; Hiltermann, Jeroen; De Looff, Margot (Biomolecules & Health); Milder, Fin (Biomolecules & Health); van den Berg, Anke; van der Wekken, Anthonie
Assessment of two new ROS1+ NSCLC patient-derived cell lines as in vitro models for TKI resistance studies
Dijkhuizen, Christa (Biomolecules & Health); Korthuis, Patrick; Aguado, Cristina; Garcia-Román, Silvia; Aguilar-Hernández, Andrés; Drayer, Lyndsay; De Looff, Margot (Biomolecules & Health); Milder, Fin (Biomolecules & Health); van der Wekken, Anthonie; van den Berg, Anke
Lectorate Biomolecules & Health
Milder, Fin
Het complementsysteem
Milder, Fin
Melt Electrowriting of Polyhydroxyalkanoates for Enzymatically Degradable Scaffolds
Gładysz, Magdalena Z.; Ubels, Didi; Koch, Marcus; Amirsadeghi, Armin; Alleblas, Frederique; Kamperman, Marleen; Siebring, Jeroen; Nagelkerke, Anika; Włodarczyk-Biegun, Małgorzata K.; van Vliet, Sander
L2026M+G2032R variant confers resistance to ROS1 tyrosine kinase inhibitors in SCL34A2-ROS1 overexpressing Ba/F3 cells through a reduced ATP binding pocket volume
Dijkhuizen, Christa (Biomolecules & Health); Korthuis, Patrick; Vilachã, Juliana F.; Smelt, Maaike; van der Wekken, Anthonie; van den Berg, Anke; Drayer, Lyndsay
SLC34A2-ROS1 L2026M+G2032R confers resistance to ROS1 tyrosine kinase inhibitors in Ba/F3 cells through a reduced ATP binding pocket volume
Dijkhuizen, Christa (Biomolecules & Health); Korthuis, Patrick; Vilachã, Juliana F.; Smelt, Maaike; van der Wekken, Anthonie; van den Berg, Anke; Drayer, Lyndsay






























